Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | PPARG | P37231 | 5/20 | 0.48 |
| ▸ | PPARA | Q07869 | 5/20 | 0.48 |
| ▸ | MAOA | P21397 | 4/20 | 0.48 |
| ▸ | MAOB | P27338 | 4/20 | 0.48 |
| ▸ | SRC | P12931 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | UNG | P13051 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | FABP4 | P15090 | 1/20 | 0.42 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.42 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.42 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.41 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2174551 | 1.00 | SMN1; SMN2 (0.55) | SMN1; SMN2PPARGPPARAMAOAMAOB | |
| SCHEMBL2552246 | 0.87 | SRC (0.45) | SMN1; SMN2MAOAMAOBSRCALDH1A1 | |
| SCHEMBL1011005 | 0.85 | AR (0.50) | SMN1; SMN2MAOAMAOBSRCALDH1A1 | |
| SCHEMBL1949996 | 0.85 | NPC1 (0.45) | SMN1; SMN2MAOAMAOBSRCALDH1A1 | |
| SCHEMBL3066415 | 0.84 | MAOA (0.44) | SMN1; SMN2PPARGPPARAMAOAMAOB | |
| SCHEMBL997736 | 0.83 | SMN1; SMN2 (0.59) | SMN1; SMN2PPARGPPARAALDH1A1 | |
| SCHEMBL1008004 | 0.82 | SRC (0.41) | SMN1; SMN2MAOAMAOBSRCALDH1A1 | |
| SCHEMBL13864205 | 0.81 | TLR4 (0.42) | SMN1; SMN2PPARGPPARAMAOAMAOB | |
| SCHEMBL4651839 | 0.80 | SMN1; SMN2 (0.64) | SMN1; SMN2PPARGPPARAALDH1A1 | |
| SCHEMBL295888 | 0.80 | SMN1; SMN2 (0.64) | SMN1; SMN2PPARGPPARAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| US-11225655-B2 | Bi-functional complexes and methods for making and using such complexes | NUEVOLUTION A/S (DK) | 2022-01-18 | — | — | US | disclosed |
| EP-3540059-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | Nuevolution A/S (DK) | 2019-09-18 | — | — | EP | disclosed |
| EP-2558577-B1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION AS (DK) | 2018-12-12 | — | — | EP | disclosed |
| US-20130281324-A1 | BI-FUNCTINAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2013-10-24 | — | — | US | disclosed |
| EP-2558577-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | Nuevolution A/S (DK) | 2013-02-20 | — | — | EP | disclosed |
| WO-2011127933-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2011-10-20 | — | — | WO | disclosed |
| US-20110046385-A1 | Polymorphs Of Prostaglandin Agonists And Methods For Making The Same | PFIZER PRODUCTS INC. (US) | 2011-02-24 | — | — | US | disclosed |
| EP-1661890-B1 | PPAR-ACTIVATING COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | KOWA CO (JP) | 2011-01-05 | — | — | EP | disclosed |
| EP-2185516-A2 | POLYMORPHS OF 3-(((4-TERT-BUTYL-BENZYL)-(PYRIDINE-3-SULFONYL)-AMINO)-METHYL)-PHENOXY)-ACETIC ACID SODIUM SALT OR A HYDRATE THEREOF AND METHODS FOR MAKING THE SAME | Pfizer Products Incorporated (US) | 2010-05-19 | — | — | EP | disclosed |
| US-7538242-B2 | Optically active PPAR-activating compound intermediate and method for producing same | KOWA CO., LTD. (JP) | 2009-05-26 | — | — | US | disclosed |
| WO-2009027811-A2 | POLYMORPHS OF 3- ( ( (4-TERT-BUTYL-BENZYL) - (PYRIDINE-3-SULFONYL) -AMINO) -METHYL) -PHENOXY) -ACETIC ACID SODIUM SALT OR A HYDRATE THEREOF AND METHODS FOR MAKING THE SAME | PFIZER PRODUCTS INC. (US) | 2009-03-05 | — | — | WO | disclosed |
| WO-2009027803-A2 | POLYMORPHS OF (3-(((4-TERT-BUTYL-BENZYL)-(PYRIDINE-3-SULFONYL)-AMINO)-METHYL)- PHENOXY)-ACETIC ACID, FREE ACID | PFIZER PRODUCTS INC. (US) | 2009-03-05 | — | — | WO | disclosed |
| US-20090023944-A1 | OPTICALLY ACTIVE PPAR-ACTIVATING COMPOUND INTERMEDIATE AND METHOD FOR PRODUCING SAME | KOWA CO., LTD. (JP) | 2009-01-22 | — | — | US | disclosed |
| WO-2008152388-A1 | SILICON-CONTAINING COMPOUNDS FOR TREATMENT OR PREVENTION OF BONE LOSS OR RESTORATION OF BONE MASS, OR AUGMENTATION OF BONE MASS | OPAL DRUG DISCOVERY LIMITED (GB) | 2008-12-18 | — | — | WO | disclosed |
| EP-1854779-A1 | OPTICALLY ACTIVE PPAR-ACTIVATING COMPOUND INTERMEDIATE AND METHOD FOR PRODUCING SAME | Kowa Company, Ltd. (JP) | 2007-11-14 | — | — | EP | disclosed |
| US-7183295-B2 | PPAR-activating compound and pharmaceutical composition comprising the compound | KOWA CO., LTD. (JP) | 2007-02-27 | — | — | US | disclosed |
| US-20060189667-A1 | PPAR-activating compound and pharmaceutical composition comprising the compound | KOWA CO., LTD. (JP) | 2006-08-24 | — | — | US | disclosed |
| EP-1661890-A1 | PPAR-ACTIVATING COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | Kowa Co., Ltd. (JP) | 2006-05-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110046385-A1 | Polymorphs Of Prostaglandin Agonists And Methods For Making The Same | PTGER1, PTGER3, PTGER4 | SMN1; SMN2 4729/4885PPARG 19/4885PPARA 26/4885 |
| US-20090023944-A1 | OPTICALLY ACTIVE PPAR-ACTIVATING COMPOUND INTERMEDIATE AND METHOD FOR PRODUCING SAME | PPARA, PPARG, PPARD | SMN1; SMN2 4832/4885PPARG 2/4885PPARA 1/4885 |
| US-20060189667-A1 | PPAR-activating compound and pharmaceutical composition comprising the compound | PPARA, PPARG, PPARD | SMN1; SMN2 4340/4885PPARG 2/4885PPARA 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.